Comparison of Chronic Rhinosinusitis Disease Control Classification Using the Chronic Rhinosinusitis Control Test Versus EPOS Criteria
- 23 October 2026
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
Abstract
Introduction: The objective of this study was to compare classification of CRS control using EPOS criteria and the Chronic Rhinosinusitis Control Test (CRCT) in a real‐world cohort of chronic rhinosinusitis (CRS) patients. Methods: CRS control was classified as controlled, partly controlled, or uncontrolled in 305 participants using EPOS and CRCT‐based classifications. Metrics of CRS disease burden included Overall Symptom Severity (OSS), disease‐specific (SNOT‐22) and general health‐related (EQ‐5D VAS) quality of life, and endoscopic disease burden (modified Lund–Kennedy [MLK] score). Convergent and divergent validity were determined by comparing CRS disease burden across different levels of CRS control for each classification scheme. Results: There was 35.7% agreement ( κ = 0.366, p < 0.001) between CRS control classification using the CRCT compared to the EPOS criteria. Consistent with how patients and providers have been previously shown to classify CRS control, the CRCT classified more participants as having controlled and partly controlled CRS compared to the EPOS criteria, which heavily skewed toward classifying participants as having uncontrolled CRS. The CRCT control classifications demonstrated convergent and divergent validity by reflecting appropriate levels of disease burden with significant differences between control classes. The EPOS classifications of controlled and partly controlled CRS lacked divergent validity, and the EPOS classification of uncontrolled CRS lacked convergent validity by including patients with very mild CRS disease burden. Conclusion: Compared to the classification scheme proposed by the EPOS guidelines, the classification of CRS control by the CRCT more closely aligns with patients’ and providers’ assessments of CRS control and has greater convergent and divergent validity.Keywords
This publication has 15 references indexed in Scilit:
- Psychometric Validation of the Overall Symptom Severity Score for Chronic RhinosinusitisOtolaryngology–Head and Neck Surgery, 2026
- Validation of Control Classifications Using the Chronic Rhinosinusitis Control Test as Comprehensive Reflections of Disease BurdenThe Journal of Allergy and Clinical Immunology: In Practice, 2026
- Patient perspectives on international multidisciplinary consensus criteria for chronic rhinosinusitis disease controlLaryngoscope Investigative Otolaryngology, 2024
- Patient‐reported disease control versus overall symptom severity as global metrics of chronic rhinosinusitis disease statusInternational Forum of Allergy & Rhinology, 2024
- Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 updateBrazilian Journal of Otorhinolaryngology, 2024
- Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease controlInternational Forum of Allergy & Rhinology, 2023
- Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health–sponsored workshopInternational Forum of Allergy & Rhinology, 2020
- The 22‐item Sino‐Nasal Outcome Test accurately reflects patient‐reported control of chronic rhinosinusitis symptomatologyInternational Forum of Allergy & Rhinology, 2017
- Modification of the lund‐kennedy endoscopic scoring system improves its reliability and correlation with patient‐reported outcome measuresThe Laryngoscope, 2014
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990